Search All Tech Briefings

Search technology briefings produced by NIHR Innovation Observatory. These are short reports on new or repurposed medicines that we have already sent to our stakeholders. Only those technologies (medicines) that are within the scope of our stakeholders will have a technology briefing available. Search our technology briefings by intervention (drug or device), specific indication (disease or condition), or general therapeutic area.

| 47 Results

Clear All Filters

Title	Intervention	Indication	Therapeutic Area	Year	Actions
Palovarotene for episodic and chronic use in fibrodysplasia ossificans progressiva – first line	Palovarotene (RG-667)	Fibrodysplasia ossificans progressiva	Musculoskeletal System	2019	View \| Download
NOVOCART 3D for articular cartilage defects of the knee	Autologous Chondrocyte Implant (NOVOCART 3D)	Articular cartilage defects	Musculoskeletal System	2019	View \| Download
Nirogacestat for treating desmoid tumours	Nirogacestat (PF-3084014;Ogsiveo)	Desmoid Tumour	Musculoskeletal System	2024	View \| Download
Nipocalimab for Generalised Myasthenia Gravis	Nipocalimab	Myasthenia gravis (MG)	Musculoskeletal System	2023	View \| Download
Mexiletine for the Symptomatic Treatment of Myotonic Disorders – First Line	Mexiletine hydrochloride (Namuscla)	Myotonia	Musculoskeletal System , Neurology	2018	View \| Download
Ixekizumab for axial spondyloarthritis	Ixekizumab (Taltz; LY2439821)	Spondyloarthritis	Musculoskeletal System , Rheumatology	2018	View \| Download
Givinostat for Duchenne muscular dystrophy	Givinostat	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2023	View \| Download
Garetosmab for preventing abnormal bone formation in fibrodysplasia ossificans progressiva	Garetosmab (REGN2477)	Fibrodysplasia ossificans progressiva	Musculoskeletal System	2020	View \| Download
Fordadistrogene movaparvovec for Duchenne muscular dystrophy	Fordadistrogene movaparvovec	Duchenne muscular dystrophy (DMD)	Genetic Disorders , Musculoskeletal System	2022	View \| Download
Efgartigimod alfa for treating generalised myasthenia gravis	Efgartigimod alfa (ARGX-113)	Myasthenia gravis (MG)	Musculoskeletal System	2021	View \| Download